MICS and minimum fungicidal concentrations of posaconazole, voriconazole and fluconazole for Cryptococcus neoformans and Cryptococcus gattii

Journal of Antimicrobial Chemotherapy

Volumn 62, Issue 1, 2008, Pages 205-206

  Torres rodríguez, Josep M ^a,b   Alvarado ramírez, Eidi ^a,b   Murciano, Francisca ^a   Sellart, Maite ^a,b  

^a Barcelona Biomedical Research Park   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Antifungals; In vitro susceptibility; Triazoles; Yeast

Indexed keywords

FLUCONAZOLE; POSACONAZOLE; VORICONAZOLE;

ANTIFUNGAL SUSCEPTIBILITY; CEREBROSPINAL FLUID; CONTROLLED STUDY; CRYPTOCOCCUS GATTII; CRYPTOCOCCUS NEOFORMANS; FUNGAL STRAIN; FUNGUS CULTURE; FUNGUS ISOLATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SEROTYPE; STATISTICAL ANALYSIS;

EID: 45749154585     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkn132     Document Type: Letter

References (6)

1. Kidd SE, Hagen F, Tscharke RL et al. A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proc Natl Acad Sci USA 2004; 101: 17258-63.
2. Pfaller MA, Messer SA, Boyken L et al. Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990-2004). J Clin Microbiol 2005; 43: 2163-7.
3. National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts - Second Edition: Approved Standard M27-A2. NCCLS, Wayne, PA, USA, 2002.
4. Bicanic T, Harrison T, Niepieklo A et al. Symptomatic relapse of HIV-associated cryptococcal meningitis after initial fluconazole monotherapy: The role of fluconazole resistance and immune reconstitution. Clin Infect Dis 2006; 43: 1069-73.
5. Aller AI, Claro R, Castro C et al. Susceptibility of Cryptococcus neoformans isolates in HIV-infected patients to fluconazole, itraconazole and voriconazole in Spain: 1994-1996 and 1997-2005. Chemotherapy 2007; 53: 300-5.
6. Espinel-Ingroff A, Fothergill A, Meter J et al. Testing conditions for determination of minimum fungicidal concentrations to new and established antifungal agents for Aspergillus spp. NCCLS collaborative study. J Clin Microbiol 2002; 40: 3204-8.